X0206 3 2019-03-11 0 0000897448 AMARIN CORP PLC\UK AMRN 0001770259 Berg Aaron C/O AMARIN PHARMA, INC. 1430 ROUTE 206 BEDMINSTER NJ 07921 0 1 0 0 CHIEF COMMERCIAL OFFICER Ordinary Shares 36351 D Restricted Stock Units 0.00 Ordinary Shares 29000 D Restricted Stock Units 0.00 Ordinary Shares 78000 D Restricted Stock Units 0.00 Ordinary Shares 38200 D Stock Option (Right to Buy) 12.60 2022-12-02 Ordinary Shares 43253 D Stock Option (Right to Buy) 1.02 2025-02-02 Ordinary Shares 3906 D Stock Option (Right to Buy) 2.50 2025-07-06 Ordinary Shares 219562 D Stock Option (Right to Buy) 1.40 2026-02-01 Ordinary Shares 36458 D Stock Option (Right to Buy) 2.95 2027-02-01 Ordinary Shares 69270 D Stock Option (Right to Buy) 2.80 2028-05-01 Ordinary Shares 117000 D Stock Option (Right to Buy) 16.87 2029-02-01 Ordinary Shares 53500 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. On February 1, 2017, the Reporting Person was granted 87,000 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019, and January 31, 2020. Not applicable. On May 1, 2018, the Reporting Person was granted 78,000 RSUs under the Plan. These RSUs vest in three equal installments on each of May 1, 2019, May 1, 2020, and May 1, 2021. On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. On December 3, 2012, the Reporting Person was granted an option to purchase 75,000 Ordinary Shares under the Plan. The shares subject to this option are fully vested as of the date hereof. On February 2, 2015, the Reporting Person was granted an option to purchase 93,750 Ordinary Shares under the Plan. The shares subject to this option are fully vested as of the date hereof. On July 6, 2015, the Reporting Person was granted an option to purchase 400,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015. On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2016. On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2017. On May 1, 2018, the Reporting Person was granted an option to purchase 117,000 Ordinary Shares under the Plan. The shares subject to this option shall vest as follows: 25% of the total number of underlying shares shall vest on May 1, 2019, and the remaining 75% of the underlying shares shall vest ratably over the subsequent 36 months. On February 1, 2019, the Reporting Person was granted an option to purchase 53,500 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 16 equal quarterly installments starting on May 15, 2019. Pursuant to Amarin's expanded commercial efforts, the company's Board of Directors has deemed Aaron Berg to be an executive officer in accordance with Section 16. /s/ Joseph Kennedy, by power of attorney 2019-03-20